Global Self-Administered Parenteral Market Report 2024: Growth Rate, Major Segments And Regions

The Self-Administered Parenteral Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Self-Administered Parenteral Market:
https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report

According to The Business Research Company’s Self-Administered Parenteral Global Market Report 2024, The self-administered parenteral market size is expected to see steady growth in the next few years. It will grow to $29.8 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%.  The growth in the forecast period can be attributed to increasing patient preference for home healthcare, telemedicine and remote patient monitoring, patient education and support initiatives, growing personalized medicine. Major trends in the forecast period include integration of digital health solutions, customized drug delivery systems, emergence of targeted therapies, advancements in biologics.

The growing incidence of chronic diseases is expected to propel the growth of the self-administered parenteral market going forward. Chronic diseases are long-lasting medical conditions that generally progress slowly over time and often require ongoing management and treatment. Self-administered parenteral products are used in the management of chronic diseases to manage treatment independently, which can significantly improve adherence compared to oral medication. For instance, in January 2023, according to the National Institutes of Health, a US-based government agency, among the population aged 50 or above, the number of people with at least one chronic disease is expected to increase by 99.5% from 71.522 million in 2020 to 142.66 million by 2050. Therefore, the growing incidence of chronic diseases is driving the growth of the self-administered parenteral market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13927&type=smp

The self-administered parenteral market covered in this report is segmented –
1) By Product: Pre-Filled Syringes, Autoinjectors, Pen Injectors, Other Products
2) By Usage: Disposable, Reusable
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Home Healthcare Providers, Specialty Clinics, Other Distribution Channels
4) By Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Other Applications

Major companies operating in the self-administered parenteral market are focusing on developing innovative products, such as the UDENYCA autoinjector, to provide increased choice and control, ultimately making treatment more accessible to patients. An autoinjector is a medical device designed to deliver a single dose of a particular drug. It is an intuitive design with administration triggered immediately and reliably by push-on-skin activation. For instance, in May 2023, Coherus BioSciences Inc., a US-based biotech company, launched the UDENYCA autoinjector, a self-administered parenteral medication in the US. The UDENYCA Autoinjector is a single-dose, prefilled autoinjector that offers patients an additional administration option for pegfilgrastim. It is designed to be intuitive, with administration triggered by push-on-skin activation, allowing for reliable and immediate delivery of a full pegfilgrastim dose. Additionally, it offers several user-friendly features that promote successful delivery, including fast dosing, intuitive design, dual coverage, at-home and in-office use, and a reduction of febrile neutropenia risk.

The self-administered parenteral market report table of contents includes:
1. Executive Summary

2. Self-Administered Parenteral Market Characteristics
3. Self-Administered Parenteral Market Trends And Strategies
4. Self-Administered Parenteral Market – Macro Economic Scenario
5. Global Self-Administered Parenteral Market Size and Growth
   .
6. Global Self-Administered Parenteral Market Competitive Benchmarking
7. Global Self-Administered Parenteral Market Competitive Dashboard
8. Key Mergers And Acquisitions In The Self-Administered Parenteral Market
9. Self-Administered Parenteral Market Future Outlook and Potential Analysis
10. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model